Skip to main content
. Author manuscript; available in PMC: 2010 Oct 1.
Published in final edited form as: Arch Ophthalmol. 2009 Oct;127(10):1250–1256. doi: 10.1001/archophthalmol.2009.276

Figure 1.

Figure 1

Kaplan-Meier curve illustrating the cumulative probability of survival during the study. The end point was defined as development of repeatable visual field loss. Dotted lines show the 95% confidence limits.